v3.25.2
Condensed Consolidated Balance Sheet (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash, cash equivalents and current restricted cash $ 271,718 $ 431,936
Accounts receivable, net 99,376 118,017
Inventory, net 66,345 56,797
Other current assets and prepaid expenses 58,883 55,339
Assets held for sale 87,011 0
Total current assets 583,333 662,089
Property, plant and equipment, net 74,937 70,134
Intangible assets, net 555,988 616,613
In-process research and development 195,000 195,000
Goodwill 484,185 529,252
Investments 13,045 54,584
Operating lease right-of-use assets 46,627 54,003
Other assets 19,874 18,537
Total assets 1,972,989 2,200,212
Current liabilities:    
Accounts payable 56,683 47,071
Accrued expenses 90,555 118,357
Current maturities of operating leases 9,919 12,649
Current portion of convertible notes 0 170
Current portion of lines of credit and notes payable 14,024 14,849
Total current liabilities 171,181 193,096
Operating lease liabilities 37,291 48,849
Long term portion of convertible notes 80,466 173,606
Senior secured notes 246,012 245,576
Deferred tax liabilities 113,328 140,799
Other long-term liabilities 27,807 32,838
Total long-term liabilities 504,904 641,668
Total liabilities 676,085 834,764
Equity:    
Common Stock - $0.01 par value, 1,250,000,000 shares authorized; 809,582,957 and 701,350,447 shares issued at June 30, 2025 and December 31, 2024, respectively 8,097 7,015
Treasury Stock - 29,799,907, and 29,799,907 shares at June 30, 2025 and December 31, 2024, respectively (1,791) (1,791)
Additional paid-in capital 3,596,392 3,481,364
Accumulated other comprehensive loss (24,730) (56,130)
Accumulated deficit (2,281,064) (2,065,010)
Total shareholders’ equity 1,296,904 1,365,448
Total liabilities and equity $ 1,972,989 $ 2,200,212

Source

HTML PDF
ZIP